Evidence map›Paper›PMID 29574541›Full record

ArticleDysphagia2018

Speech Therapy as Treatment for Supragastric Belching.

Liesbeth Ten Cate, Thomas V K Herregods, Philippe H Dejonckere, Gerrit J M Hemmink, André J P M Smout, Albert J Bredenoord

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Dysphagia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Diagnostic and Management Review of Gastric and Supragastric Belching, Aerophagia, and Rumination Syndrome.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Chronic Burping and Belching.Current treatment options in gastroenterology · 2020
    Review
  10. Supragastric belching: Pathogenesis, diagnostic issues and treatment.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Liesbeth Ten CateStem en Spraak (Voice and Speech), Logopedie aan de Amstel, Herengracht 500, 1017 CB, Amsterdam, The Netherlands. ltencate@xs4all.nl.ORCID 0000-0001-8428-5207
Thomas V K HerregodsDepartment of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Philippe H DejonckereKULeuven, Neurosciences & Federal Agency for Occupational Risks, Brussels, Belgium.
Gerrit J M HemminkDepartment of Gastroenterology, Isala, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands.
André J P M SmoutDepartment of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Albert J BredenoordDepartment of Gastroenterology and Hepatology, Academic Medical Center, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Amsterdam UMC Location University of Amsterdam · NLFederal Agency for Nuclear Control · BEIsala · NLTata Steel (Netherlands) · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to describe a newly developed speech therapy program as an innovating therapeutic approach and to assess the results of this intervention in patients with supragastric belching. This is a retrospective analysis of prospectively gathered data from 73 patients with supragastric belching who were treated with speech therapy between 2007 and 2017. Of these, 48 were included for evaluation of therapy. Thirty patients had supragastric belching proven by 24-h impedance measurements. Eighteen patients were diagnosed by an experienced speech language pathologist as having supragastric belching according to precise criteria. Speech therapy consists of explanation, creating awareness of esophageal air influx and exercises to discontinue the supragastric belching mechanism. Therapy effect was measured by comparing visual analogue scale (VAS) scores on belching and related symptoms. The median symptom duration at the start of therapy was 2 years. Supragastric belching symptoms decreased significantly with a total median VAS score of 406 (291-463) prior to treatment and a median VAS score of 125 (17-197) following treatment. Forty patients (83%) had a sufficient to major result with a median therapy duration of 3 months and ten sessions. Speech therapy was an effective treatment in the majority of patients with supragastric belching.

Indexed as

EructationEsophagusFemaleHumansMaleMiddle AgedPilot ProjectsRetrospective StudiesSpeech TherapyAbdominal breathingAir inhalationAir injectionDeglutitionDeglutition disordersGlottal closureSpeech therapySupragastric belching

Identifiers

PMID29574541
OpenAlexW2793252707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.